Asset Details

MbrlCatalogueTitleDetail

Do you wish to reserve the book?

Expert eValuation of Efficacy and Rationality of Vildagliptin “EVER-Vilda”: An Indian Perspective

by Kalra, Sanjay , Ahmed, Jamal , Joshi, Ameya , Ramakrishnan, Santosh , Ganguly, Kajal , Vijayakumar, G , Kumar, Ajay , Sridhar, GR , Ayer, Vageesh , Das, Ashok Kumar , Jindal, Sushil , Unnikrishnan, AG , HK, Ganesh , Dhingra, Atul , George, Joe , Sharma, Balram , Zargar, Abdul Hamid , Srinivas, Arun , Kapoor, Nitin , Mohan, Jagdish Chander , Shah, Chetan , Baruah, Manash P , Pandit, Kaushik , Ray, Saumitra , Sahay, Rakesh Kumar , Mittal, Sachin , Bantwal, Ganapathi

in Antidiabetics / Cardiology / Clinical medicine / Combination therapy / Diabetes / Drug dosages / Endocrinology / Glucagon / Glucose / Hospitals / Hyperglycemia / Hypoglycemia / Medical schools / Older people / Peptides

2024

Yes Please

Hey, we have placed the reservation for you!

By the way, why not check out events that you can attend while you pick your title.

Oops! Something went wrong.

Looks like we were not able to place the reservation. Kindly try again later.

Are you sure you want to remove the book from the shelf?

Expert eValuation of Efficacy and Rationality of Vildagliptin “EVER-Vilda”: An Indian Perspective

2024

Confirm

Do you wish to request the book?

Expert eValuation of Efficacy and Rationality of Vildagliptin “EVER-Vilda”: An Indian Perspective

2024

Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy

How would you like to get it?

Submit

We have requested the book for you!

Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.

Oops! Something went wrong.

Looks like we were not able to place your request. Kindly try again later.

Journal Article

Expert eValuation of Efficacy and Rationality of Vildagliptin “EVER-Vilda”: An Indian Perspective

Kalra, Sanjay,

Ahmed, Jamal,

Joshi, Ameya,

Ramakrishnan, Santosh,

Ganguly, Kajal,

Vijayakumar, G,

Kumar, Ajay,

Sridhar, GR,

Ayer, Vageesh,

Das, Ashok Kumar,

Jindal, Sushil,

Unnikrishnan, AG,

HK, Ganesh,

Dhingra, Atul,

George, Joe,

Sharma, Balram,

Zargar, Abdul Hamid,

Srinivas, Arun,

Kapoor, Nitin,

Mohan, Jagdish Chander,

Shah, Chetan,

Baruah, Manash P,

Pandit, Kaushik,

Ray, Saumitra,

Sahay, Rakesh Kumar,

Mittal, Sachin,

Bantwal, Ganapathi

2024

Overview

Vildagliptin, a dipeptidyl peptidase-4 (DPP-4) inhibitor is effective in reducing HbA1c levels in patients with type 2 diabetes (T2DM) when administered as monotherapy, dual or triple combination therapy. In India, Vildagliptin is commonly prescribed in T2DM patients because it reduces mean amplitude of glycemic excursion (MAGE), has lower risk of hypoglycemia and is weight neutral. Early combination therapy with vildagliptin and metformin is effective and well-tolerated in patients with T2DM, regardless of age or ethnicity. In view of already existing data on vildagliptin and the latest emerging clinical evidence, a group of endocrinologists, diabetologists and cardiologists convened for an expert group meeting to discuss the role and various combinations of vildagliptin in T2DM management. This practical document aims to guide Physicians and Specialists regarding the different available strengths and formulations of vildagliptin for the initiation and intensification of T2DM therapy.

Share this book

Add to My Shelf

Publisher

SAGE Publications,Sage Publications Ltd,SAGE Publishing

Subject

Antidiabetics

/ Cardiology

/ Clinical medicine

/ Combination therapy

/ Diabetes

/ Drug dosages

/ Endocrinology